Maintenance Olaparib Benefits Sustained Beyond 2 Years Treatment Maintenance Olaparib Benefits Sustained Beyond 2 Years Treatment

Women with newly diagnosed ovarian cancer and a BRCA mutation see sustained benefits in progression free survival rates after two years of maintenance olaparib therapy, a clinical trial analysis suggests.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news